Developmental and Epileptic Encephalopathy Clinical Trials

11 clinical trials for Developmental and Epileptic Encephalopathy across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — RECRUITING · PHASE3
• Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data — RECRUITING
• A PHASE 3, OPEN-LABEL STUDY TO INVESTIGATE THE LONG-TERM SAFETY AND EFFICACY OF LP352 IN THE TREATMENT OF SEIZURES IN CHILDREN AND ADULTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF LP352 IN THE TREATMENT OF SEIZURES IN CHILDREN AND ADULTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES — RECRUITING · PHASE3
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — ACTIVE_NOT_RECRUITING · PHASE3
• A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE — NOT_YET_RECRUITING · PHASE3
• A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy — TERMINATED · PHASE1
• Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing — NOT_YET_RECRUITING
• Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy — ACTIVE_NOT_RECRUITING · PHASE1
• Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy — COMPLETED · PHASE2
• Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies — COMPLETED · PHASE1

Refine this search